Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 16:37:12778.
doi: 10.3389/ti.2024.12778. eCollection 2024.

Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series

Christophe Masset  1   2 , Claire Garandeau  1 , Simon Ville  1   2 , Magali Giral  1   2 , Aurélie Houzet  1 , Julien Branchereau  1   2 , Ismaël Chelghaf  1 , Benoit Mesnard  1   2 , Gilles Blancho  1   2 , Jacques Dantal  1   2 , Diego Cantarovich  1
Affiliations

Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series

Christophe Masset et al. Transpl Int. .
No abstract available

Keywords: belatacept conversion; calcineurin inhibitor toxicity; pancreas allograft function; pancreas transplantation; rejection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Stock PG, Mannon RB, Armstrong B, Watson N, Ikle D, Robien MA, et al. Challenges of Calcineurin Inhibitor Withdrawal Following Combined Pancreas and Kidney Transplantation: Results of a Prospective, Randomized Clinical Trial. Am J Transpl (2020) 20:1668–78. 10.1111/ajt.15817 - DOI - PMC - PubMed
    1. Cantarovich D, Kervella D, Karam G, Dantal J, Blancho G, Giral M, et al. Tacrolimus-Versus Sirolimus-Based Immunosuppression After Simultaneous Pancreas and Kidney Transplantation: 5-Year Results of a Randomized Trial. Am J Transpl (2020) 20:1679–90. 10.1111/ajt.15809 - DOI - PubMed
    1. Wisel SA, Posselt AM, Szot GL, Nunez M, Santos-Parker K, Gardner JM, et al. A Multi-Modal Approach to Islet and Pancreas Transplantation With Calcineurin-Sparing Immunosuppression Maintains Long-Term Insulin Independence in Patients With Type I Diabetes. Transpl Int (2023) 36:11367. 10.3389/ti.2023.11367 - DOI - PMC - PubMed
    1. Terrec F, Jouve T, Naciri-Bennani H, Benhamou PY, Malvezzi P, Janbon B, et al. Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters. Transpl Direct (2020) 6:e517. 10.1097/TXD.0000000000000964 - DOI - PMC - PubMed
    1. Gallo E, Abbasciano I, Mingozzi S, Lavacca A, Presta R, Bruno S, et al. Prevention of Acute Rejection After Rescue With Belatacept by Association of Low-Dose Tacrolimus Maintenance in Medically Complex Kidney Transplant Recipients With Early or Late Graft Dysfunction. PLOS ONE (2020) 15:e0240335. 10.1371/journal.pone.0240335 - DOI - PMC - PubMed